WWOX Antikörper (AA 5-100)
-
- Target Alle WWOX Antikörper anzeigen
- WWOX (WW Domain Containing Oxidoreductase (WWOX))
-
Bindungsspezifität
- AA 5-100
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser WWOX Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus
- Homologie
- Rat
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human WWOX
- Isotyp
- IgG
- Top Product
- Discover our top product WWOX Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients." in: Diagnostic pathology, Vol. 7, pp. 181, (2013) (PubMed).
: "
-
The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients." in: Diagnostic pathology, Vol. 7, pp. 181, (2013) (PubMed).
-
- Target
- WWOX (WW Domain Containing Oxidoreductase (WWOX))
- Andere Bezeichnung
- WWOX (WWOX Produkte)
- Synonyme
- CG7221 antikoerper, DmWWOX antikoerper, Dmel\\CG7221 antikoerper, anon-EST:Posey177 antikoerper, GB11795 antikoerper, WWOX antikoerper, D16S432E antikoerper, FOR antikoerper, FRA16D antikoerper, HHCMA56 antikoerper, PRO0128 antikoerper, SDR41C1 antikoerper, WOX1 antikoerper, zgc:55975 antikoerper, 5330426P09Rik antikoerper, 9030416C10Rik antikoerper, WW domain containing oxidoreductase antikoerper, WW domain-containing oxidoreductase antikoerper, Wwox antikoerper, LOC411815 antikoerper, WWOX antikoerper, CpipJ_CPIJ004939 antikoerper, MCYG_01584 antikoerper, VDBG_05631 antikoerper, VDBG_01326 antikoerper, VDBG_06753 antikoerper, Tsp_03967 antikoerper, LOC100284583 antikoerper, wwox antikoerper
- Hintergrund
-
Synonyms: FOR, WOX1, EIEE28, FRA16D, SCAR12, HHCMA56, PRO0128, SDR41C1, D16S432E, WW domain-containing oxidoreductase, Fragile site FRA16D oxidoreductase, Short chain dehydrogenase/reductase family 41C member 1, WWOX
Background: Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm.
- Gen-ID
- 51741
- UniProt
- Q9NZC7
-